Oklo Shares Gain on DOE Clearance to Begin Research, Demonstration at Isotope Test Reactor
By Kelly Cloonan
Shares of Oklo rose after the company got clearance from the Department of Energy to start unrestricted operations for its Groves Isotope Test Reactor (Groves-1).
The stock gained 7.2% to $26.90 in premarket trading Wednesday. At Tuesday's market close, shares were down 65% year to date.
The nuclear technology company said the clearance allows the facility to advance to its research, testing and training phase.
With the clearance, Oklo said it plans to test the facility's capabilities relevant to future isotope reactors and the company's fast-fission reactors.
In particular, Groves-1's operating experience will inform Groves-2 Forge, Oklo's planned isotope production and processing pilot facility, the company said.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
November 11, 2026 08:25 ET (13:25 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular

4 Growth Stocks to Buy While They’re Still Undervalued

3 of the Best Core Stocks to Own

The 10 Best Companies to Invest in Now

Your Year-End Financial Checklist: 5 Things to Tackle Before 2027

